Ricerca avanzata

Home > Riviste > Minerva Biotecnologica > Fascicoli precedenti > Minerva Biotecnologica 2016 Settembre;28(3) > Minerva Biotecnologica 2016 Settembre;28(3):159-63



Rivista di Biologia Molecolare e Biotecnologie

Indexed/Abstracted in: EMBASE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,246

Periodicità: Trimestrale

ISSN 1120-4826

Online ISSN 1827-160X


Minerva Biotecnologica 2016 Settembre;28(3):159-63


High trimethoprim-sulfamethoxazole resistance in ciprofloxacin-resistant Escherichia coli strains isolated from urinary tract infection

Neslihan İDİL 1, Esra D. CANDAN 1, Abbas YOUSEFI RAD 2, Nilüfer AKSÖZ 1

1 Department of Biology, Faculty of Sciences, Hacettepe University, Ankara, Turkey; 2 Department of Medical Microbiology, Yüksek Ihtisas University, Ankara, Turkey

BACKGROUND: Escherichia coli is the most frequently isolated pathogen of urinary tract infections. Rising rates of resistance to antimicrobial agents among E. coli leads to limit treatment options for these infections. The aims of this study were to evaluate resistance patterns of uropathogenic E. coli against antimicrobial agents which can be used in healthcare for the treatment of UTI and to examine particularly an association between resistance to ciprofloxacin and trimethoprim sulfamethoxazole.
METHODS: A total of 1123 E. coli strains were obtained consecutively from urine specimens in research and private hospital, during 2010-2011. Ampicillin, ceftazidime, ceftriaxone, cefazolin, ciprofloxacin, ertapenem, gentamicin, imipenem, nitrofurantoin, piperacillin-tazobactam and trimethoprim-sulfamethoxazole (TMS-SMX) resistance were determined by automated system.
RESULTS: Among tested antibiotics, imipenem had the best efficient antibiotic against all E. coli strains (100%), followed by ertapenem (99.98%), amikacin (99.94%), and nitrofurantoin (99.91%). A statistically significant difference has been found for the resistance of non-ESBL and ESBL-producing E. coli strains against gentamicin, piperacilin-tazobactam, ciprofloxacin and TMP-SMX (P<0.001). 13.1% of strains were extended-spectrum beta-lactamase (ESBL) producers, 19.5% of strains were ciprofloxacin-resistant (CIP-R) and 34.6% of strains were TMS-SMX-resistant. TMP-SMX (63%) had the highest resistance among CIP-R urinary E. coli strains tested in this study.
CONCLUSIONS: The findings of this study has indicated that there was a strong correlation between the occurrence of ESBL and the development of ciprofloxacin resistance. High resistance both ciprofloxacin and TMP-SMX and an association between resistance to these two antimicrobial agents in uropathogenic E. coli strains has not been previously reported and warrants further study.

lingua: Inglese


inizio pagina